SPEAKERS

An international dialogue to improve health

REGISTER NOW

FABRICE BRUNET

President of the Conference of the CHU of Quebec

Dr. Brunet is the Director General and CEO of CHU Sainte-Justine since 2009. He is also the President of the Conference of the CHU of Quebec, as well as the Vice-President of the University of Montreal Health Network (RUIS).

Read more

Among his many accomplishments are the development of a Clinical Research Program in Critical Care and a Cardiac Surgery Centre in Paris; the design of a private hospital project in Saint Petersburg, Russia and the creation of an academic Critical Care Department in Toronto.

At CHU Sainte-Justine, he is overseeing numerous modernization projects, including the construction of a new research centre and a state of the art building for specialized care units with a total budget of $1 billion.

Born in Paris, Dr. Brunet completed his medical studies at the Faculty of Medicine Cochin Port Royal, University of Paris V. He is board certified in cardiology, intensive care and emergency medicine. Dr. Brunet went on to complete his studies in management at Harvard and the University of Toronto. Until his arrival at CHU Sainte-Justine, he was the Chief of the Department of Critical Care at St. Michael's Hospital in Toronto and the Medical Director of their Telemedicine Program. He has extensive experience in clinical research, education and hospital management with numerous publications in peer reviewed journals and chapters in textbooks. His main fields of interest are knowledge management in medicine, healthcare network development and improvement in global performance.

During the last four years at CHU Sainte-Justine Dr. Brunet has implemented a model of management integrating care, research and education to continuously improve global performance. Concomitantly CHU Sainte-Justine has increased its involvment in the Quebec Healthcare Network for integrated maternal and child care. The whole transformation of the hospital was facilitated through an international knowledge management network, developed in 2002, which provided additional human resources and scientific knowledge.

SPEAKERS

SEE THE PROGRAM

ANDREW RILEY (Grande-Bretagne)

RELATED THEMES
Innovation

INTERVENTION TITLE
Innovation, Health, Wealth (IHW); First year review of the Academic Health Science Networks in the NHS

Complete profile
 

AHMED MAHERZI MD (Tunisia)

RELATED THEMES
Field Knowledge Management

INTERVENTION TITLE
The new mission of the Faculty of Medicine based on the principles of social responsibility

DR. NARENDRA KINI MD MHA
(United States)

- President and CEO of Miami Children's Health Sytem and Miami Children's Hospital

RELATED THEMES
TeleHealth

INTERVENTION TITLE
Virtual Medicine: a primer

DAVID LEVINE (Canada)

RELATED THEMES
Personalized Health

INTERVENTION TITLE
The Future for Personalized medicine: Can this really change our health care system?

+ 20 panelists and more than 30 presentations
(workshops and case studies)

REGISTER NOW

+
A1
Carl-Éric Aubin - CHUSJ - Co-Creation of the Surgery Unit of the Future for Spinal Deformities

Carl-Eric Aubin, PhD, Eng.

Carl-Éric Aubin - CHUSJ - Co-Creation of the Surgery Unit of the Future for Spinal Deformities

A co-creation process involving a wide variety of specialists from various disciplines and backgrounds (engineers, architects, surgeons, anesthetists, radiologists, communication and computer science technologists, etc.) resulted in the design of a hybrid operating room connected to an imaging and prototyping unit.

This project will allow the development of innovative, minimally invasive surgical procedures intended for spinal disorders, thereby optimizing the effectiveness of such interventions and providing real-time feedback using state-of-the art digital simulations, 3D fluoroscopic imaging and navigation systems, and spectroscopic endoscopy imaging.

Simulations drawn from X-rays of patients suffering from scoliosis allow for testing various surgical instrumentation procedures so as to define the best one, before the

Carl-Eric Aubin, PhD, Eng.is a full professor in the Department of Mechanical Engineering at École Polytechnique, an associate professor in the Department of Surgery at Université de Montréal and Head of the research axis for the Musculoskeletal Diseases and Readaptation Centre. Dr. Aubin is Chairholder of NSERC/Medtronic Research Chair in Spine Biomechanics and Chairholder of Polytechnique's Excellence Research Chair in Orthopedic Engineering. Dr. Aubin is a world leading expert in biomedical technologies that allow for the development of modeling and assessment tools for spinal deformities to help anticipate the outcomes of orthopaedic treatments and optimize their performance.

+
A2
Julie Béliveau - Université de Sherbrooke - Planetree Model implementation research results

Julie Béliveau

Julie Béliveau - Université de Sherbrooke - Planetree Model implementation research results

How can we effectively accelerate the transfer of a person-centered approach such as Planetree while ensuring the long-term implementation of intended shifts in the healthcare system? This participatory action research approach seeks to answer this question. Throughout this conference, the main researcher in this project will introduce the various findings this study revealed.

Julie Béliveau Julie Béliveau is a Professor in the Department of management and HRM at the Faculty of Administration of the Université de Sherbrooke, in Quebec, Canada. She is the principal researcher of this research project financed by the Canadian Institutes for Health Research (CIHR). She teaches courses in knowledge transfer and management decision. Her research interests are: knowledge transfer, middle managers, management of patient-centered care, behavioral exemplarity and qualitative research methodologies.

+
A3
Chantale Lessard - Covidien - The contribution of the health economy in the decisions of health innovation

Chantale Lessard, BPharm, MSc, PhD, DiplCompl AnEIS

Chantale Lessard - Covidien - The contribution of the health economy in the decisions of health innovation

Given the ever-increasing rise in the demand for healthcare services and forcefulness of technological advancement (and constant upward trend of health costs) in a context of scarce resources and cost control, healthcare leaders must continually assess the worth of added value in healthcare innovations. Health economics offers an explicit and compelling normative framework for the formulation of decision-making policies and assessments, its aim being to optimize and improve allocative quality, efficiency and efficacy to ensure a transparent and responsible decision taking responsibility.

Chantale Lessard, BPharm, MSc, PhD, DiplCompl AnEISDirector, Health Economics and Reimbursement
Health System Solutions
Covidien

Chantale Lessard est pharmacienne et titulaire d'une maîtrise en sciences pharmaceutiques, option Évaluation et Pharmacoéconomie, d'un Ph.D. en santé publique, option Organisation des soins de santé, d'un diplôme complémentaire de 3e cycle en Analyse et Évaluation des Interventions en Santé (AnÉIS) et d'une formation postdoctorale en Économie de la santé. Conférencière dynamique et expérimentée, madame Lessard possède une riche expérience professionnelle acquise dans divers milieux : académique; industrie des technologies médicales; organismes gouvernementaux ou universitaires en évaluation des technologies de la santé; industrie pharmaceutique; pharmacie communautaire. Elle est actuellement Directrice, Économie et remboursement des soins de santé chez Covidien.

+
A4
Garry Savage - CHUSJ -The Technopole Project

Garry Savage

Garry Savage - CHUSJ -The Technopole Project

CHU Sainte-Justine's technopolis was born out of a shared determination to improve the management of physical disabilities using technological and scientific innovation. This project draws on the expertise developed at CHU Sainte-Justine' Marie Enfant Rehabilitation Centre namely their research centre and knowledge centre as well as on the partnership of various institutional and private business associates.

This major project would see the creation of a pediatric rehabilitation research and development hub.

This presentation will address the project's main innovative components and the process of enhancing and optimizing research project outcomes.

Garry Savage En 2013, Garry Savage joint l'équipe du CHU Sainte-Justine de Montréal à titre de directeur du Centre de développement et de transfert technologique du futur Technopôle (CD3T). Son principal mandat vise à définir le concept du projet de la Cité international de réadaptation pédiatrique du CHU Sainte-Justine. Il consiste aussi à coordonner la mise en chantier du pavillon du Technopôle qui s'inscrit dans le plan directeur.

Sur le plan de la recherche et du développement, son mandat vise à mettre en place une plateforme novatrice de valorisation permettant aux chercheurs, cliniciens et professionnels de la santé de développer leurs projets avec des partenaires académiques et industriels selon les critères techniques requis pour maximiser leurs transferts vers l'industrie. Il contribue également à instaurer un milieu d'échanges créatifs et à mettre en place des partenariats stratégiques avec des entreprises pour le développement, la validation et la mise en marché de technologies innovantes en réadaptation pédiatrique.

+
A5
William Fraser - Sherbrooke UHC (CHUS) - Role of the multi-centric trials in the changes of medical practice

William Fraser

William Fraser - Sherbrooke UHC (CHUS) - Role of the multi-centric trials in the changes of medical practice

Clinical Practice Guidelines, according to evidence based principals, should be based on evidence from large carefully conducted randomized clinical trials. Data from industry sponsored studies serve as the basis for the assessment of new drugs by regulatory agencies. But what is the source of sponsorship for studies that assess medications that are ¿repurposed', that is medications that have the potential to benefit conditions other than those for which there were initially designed? Similarly, while industry often conducts placebo controlled studies, the most relevant question to clinicians is ¿How does a new drug perform relative to the existing standard of care?' ¿ so-called ¿management trials'. The pharmaceutical industry has little interest in sponsoring either of these types of studies. Traditionally, trials of repurposed medications, as well as management trials, have been sponsored by publically funded agencies, within the peer review process. Proposals with the highest scientific merit have been funded through dedicated funding envelopes, based on the principal that this important investment is justified as it is this area of science is most likely to have a direct impact on patient outcomes. However, the plateauing of budgets at our national research funding agencies has resulted in this type of clinical research coming under serious threat. As a result, it has become increasingly difficult to secure funding for large investigator initiated trials from public funding agencies. The health care community must take a position as to whether it considers that large investigator initiated clinical trials are important to improving clinical care and managing the health care system. In other words, do we want health practices to continue to be grounded in strong evidence. If we do, governments and their funding agencies must make the commitment to invest in this area of research.

William Fraser Dr Fraser est professeur titulaire au Département d'obstétrique-gynécologie à l'Université de Sherbrooke et directeur du Centre de recherche du CHUS. Il est titulaire d'une Chaire de recherche du Canada en médecine f¿to-maternelle. Il a une expérience de 25 ans dans le domaine des essais cliniques randomisés (ECR).

+
A6
Luc Sirois - Hacking Health

Luc Sirois

Luc Sirois - Hacking Health

Continually striving to improve its performance as a health institution and in order to better meet the needs of the population, CHU Sainte-Justine, together with Hacking Health, are leading a genuine revolution in the ways to identify and put into concrete form the best ideas, hand in hand with technology and creative communities surrounding them. A new and innovative approach on the horizon¿

Luc Sirois

+
A7
Alexandre Berkesse -Université de Montréal - Mobilization of experiential knowledge of patients

Alexandre Berkesse

Alexandre Berkesse -Université de Montréal - Mobilization of experiential knowledge of patients

On a daily basis, throughout North America, one in every two people lives with at least one chronic condition. Though this number clearly illustrates the substantial challenge faced by the healthcare system which is already pushed to the breaking point, what we offer here is a reflection on how to look at it as an unexpected source of creativity for transforming the healthcare settings of the future. While health professionals are experts in diseases, patients and their loved ones are the real experts in living with the disease. At Université de Montréal's Direction Collaboration et Patient Partenaire (DCPP), we have chosen to foster an approach that sees these two worlds which actually coexist in daily life, meeting on common ground and building together a partnership. Our proposal: empowering patients to become long-lasting partners in the healthcare mission, in teaching and institutional healthcare research by tapping into their experiential backgrounds derived from their life with the disease by creating a health care partnership between health professionals, health managers and patients.

Alexandre Berkesse Consultant en management, chercheur doctorant en Philosophie, Alexandre Berkesse a été le chef de projet pour la réforme du programme de médecine de l'Université de Montréal où il a notamment, grâce au projet de Vincent Dumez, initié l'intégration des patients à la co-construction de l'enseignement en sciences de la santé. Depuis, il agit en tant que conseiller sénior dans le déploiement du partenariat patient dans les projets d'amélioration continue du projet Lean Santé phase 2 du MSSSQ.

+
A8
Marie-Hélène Jobin - HEC Montréal - A compass to direct the Lean method

Marie-Hélène Jobin

Marie-Hélène Jobin - HEC Montréal - A compass to direct the Lean method

Several major innovations regarding organizational policies and practices are fuelled by the Lean approach. Managers must break new ground on numerous fronts to assist in the implementation of this new culture. Losing track of the big picture is easy. Guidelines for assessing where we stand in the transformation of the culture and what fields must be addressed are essential for health establishments. This presentation speaks of a tool for assessing organizational project management maturity that was developed by Pôle santé and the Chair at IRISS and introduces the building blocks of a successful Lean approach.

Marie-Hélène Jobin Directrice du Pôle Santé HEC Montréal
Responsable du profil de spécialisation Gestion des opérations et logistique du MBA
Professeure titulaire, Département de la gestion des opérations et de la logistique
HEC Montréal

+
A9
Alain Biron et Anaick Briand - MUHC - Transforming Care at the Bedside (TCAB)

Alain Biron

Anaick Briand

Alain Biron et Anaick Briand - MUHC - Transforming Care at the Bedside (TCAB)

As of 2010, McGill University Health Centre (MUHC) has been implementing its Transforming Care at the Bedside (TCAB) program at the institution's six sites. Overall, more than one hundred staff members and patient representatives have taken part among other things in the increase of direct patient care. Positive outcomes have been achieved more specifically regarding the development of transformational leadership skills and the improvement of health care quality and security. The methods used and results achieved from this participatory approach will be described and practical cases will be introduced.

Alain BironAlain Biron est adjoint au Directeur du Département de la qualité, sécurité des soins, et de la performance au Centre universitaire de santé McGill et Professeur adjoint à l'École des sciences infirmières de l'Université McGill. Il détient un doctorat en sciences infirmières de l'université McGill en administration des services infirmiers. Au cours des trois dernières années, il a été impliqué dans des projets soutenant la participation des patients dans les démarches d'amélioration de la qualité ainsi que la mesure de l'expérience des patients au niveau local, national et international. Il a publié dans le domaine de l'amélioration de la qualité, la participation des patients et la sécurité des soins.

 

+
A10
Sabrina Hasham - Chaya - CHAYA : A telemedicine platform

Sabrina Hasham

Sabrina Hasham - Chaya - CHAYA : A telemedicine platform

Sabrina Hasham

+
A11
Jorge Juan Fernandez - Hospital San Juan de Déu, Spain - The Liquid Hospital

Jorge Juan Fernandez

Jorge Juan Fernandez - Hospital San Juan de Déu, Spain - The Liquid Hospital

What is a Liquid Hospital? This initiative by Hospital Sant Joan de Déu (HSJD) encompasses more than 20 projects seeking to radically transform healthcare through an intensive use of technologies oriented towards the patient. HSJD aims to be a Liquid Hospital, providing services and content for the patients beyond the physical buildings of the hospital. HSJD is the most relevant example in Europe where a hospital is using online care, telemedicine, mobile apps and health 2.0 tools to put the patient in the center of care.
The only reason why we are interested in technologies is because they can help us solve the healthcare conundrum. Or can you think of any better ways of providing better care, at a lower cost, and more accessible?

Jorge Juan Fernandez

+
A13
Martine Dallaire & Louis-Jacques Lalonde - Quebec UHC - Téléthrombolysis in RUIS, Université Laval

Martine Dallaire

Louis-Jacques Lalonde

Martine Dallaire & Louis-Jacques Lalonde - Quebec UHC - Téléthrombolysis in RUIS, Université Laval

Every second counts for a brain affected by a stroke. The faster the patient can be directed to specialty care, the greater the chances of recovery. When patients suffering from a stroke live near a specialized stroke centre, they are liable to recover with minor or no lasting consequences. Access to telethrombolysis at Laval's RUIS brought experts together.

Martine DallaireMartine Dallaire est détentrice d'une maîtrise en sciences infirmières et d'un diplôme de 2e cycle en gestion et développement des organisations de l'Université Laval. Elle est adjointe au directeur clientèle volet neurosciences au CHU de Québec et conférencière dans plusieurs congrès internationaux. Au cours de son cheminement de carrière, elle a cumulé de nombreuses responsabilités dans la mise en ¿uvre de soins intégrés dans différents milieux cliniques. Elle s'intéresse à la gestion intégrée des soins et services dans une perspective d'un continuum de soins et services harmonieux pour la clientèle. Elle a participé comme co-auteur à l'écriture de différents articles et chapitres de livre avec comme thèmes la transition et la pratique infirmière avancée.

Louis-Jacques Lalonde Titulaire d'un diplôme d'ingénieur informatique, incluant une spécialisation en architecture des systèmes, et d'une maîtrise génie biomédical, avec des spécialisations en génie clinique ainsi qu'en télésanté. À l'emploi du CHU de Québec depuis 2005, il occupe actuellement le poste d'Adjoint au directeur, pôle de la télésanté et des développements informatiques régionaux en plus d'être coordonnateur du centre de service et de coordination en télésanté pour le territoire du RUIS UL.

+
A14
Dr. Deborah Radcliffe-Branch, PhD & Mario Di Carlo (MUHC) &  - Peer training for self-management: My Tool Box

Deborah Radcliffe-Branch

Mario Di Carlo

Mario Di Carlo (MUHC) & Deborah Radcliffe-Branch (McGill University) -Peer training for self-management: My Tool Box

Care for people with chronic diseases now consumes the largest share of the health care budget and is expected to rise significantly in the decades to come as the population ages. Sustainable best practices to address the problem of chronic disease management are needed to work within existing operations and must be flexible in terms of implementation. Interventions such as the Stanford CDSMP (known locally as My Tool Box/L'Atelier) have considerable effect due to the: potential scalability of the interventions, relative low cost to implement, wide application across settings and illnesses, and the capacity to reach large numbers of people.

Deborah Radcliffe-Branch, PhD
Dr. Radcliffe-Branch joined the Montreal Neurological Institute and Hospital (MNI/MNH) in July 2007 as Assistant Professor in the Faculty of Medicine, and was subsequently appointed Director of ¿My Tool Box', the MUHC's Chronic Disease Self-Management program (Stanford model). Dr. Radcliffe-Branch implemented this unique patient and data driven program in English and French across five MUHC hospital sites. She oversees all program activities including adherence to the Stanford protocols and program evaluation, in addition to statistical analysis of patient outcomes. She has spearheaded the expansion and development of the Stanford CDSMP in select McGill RUIS territories, several regions across Quebec, and overseas.
Prior to accepting this position, Dr Radcliffe-Branch completed a post-doctoral fellowship at Université de Montréal in the areas of patient-physician communication and older women's health. She was awarded her PhD in 2005 and MA 2000, both in Educational Psychology from McGill University, and her BA in Psychology (with distinction) from Concordia University in 1997. The focus of Dr Radcliffe-Branch's professional career has been to implement and evaluate educational and supportive programs for individuals living with chronic illness/es, emphasizing patient self-management.  An in-demand speaker, she has shared her expertise at conferences in Abitibi-Témiscamingue, Montreal, Toronto, Ottawa, Cincinnati, Florida, and Seattle; she frequently presents to health care professionals as well as community and disease-based organizations and groups. She is a member of the Advisory Board of the Patient Resource Centre of the MNI/MNH and is the recipient of numerous grants and awards from: the Association des paraplegiques du Québec, Fondation pour la recherche sur la moelle épiniere, the Rick Hansen Institute, and most recently the McGill Centre of Excellence on Aging and Chronic Diseases (CEACD).
 

Mario Di CarloMario Di Carlo has held management and senior management positions in international and crown corporations since the 1980's. His role has essentially focused on customer service and sales.

Over the years, he began to use his personal and professional experience, combined with his passion for service, to help bring forward causes dear to his heart. Thus, he got involved on the ground and on the board of various non-profit organizations dealing with issues related to health, poverty and education such as Polio Quebec Association, Butterfly Wings Foundation, Association québécoise de la douleur chronique, West Island Mission, The Refuge and the Royal Astronomical Society of Canada.

The year 2007 is the beginning of his involvement at the McGill University Health Centre (MUHC). He was asked to participate in a pilot project as a facilitator for the Chronic Disease Self-Management Program (CDSMP) of Stanford University, known as "My Toolbox" at the MUHC. This program has had a huge success among people living with chronic conditions and Mr. Di Carlo has played a key role in spreading the program across Quebec. He is a certified T-Trainer for CDSMP. His involvement now includes being Co-Chair of the Montreal Neurological Hospital Users' Committee, Executive Member of the MUHC Users' Committee, Patient Representative of the Transforming Care at the Bedside (TCaB) project and member of the Vigilance Committee.

Mario Di Carlo holds a Bachelor of Arts in Translation from Concordia University. He participated in editing the French version of Living a Healthy Life with Chronic Conditions (third and fourth edition), as well as in translating the Workbook and Leader Manual of the Chronic Pain Self-Management Program (CPSMP). He speaks several languages and is fluent in both English and French.

+
A15
Jacques Michaud - CHUSJ - Pediatric genomics platform

Jacques Michaud

Jacques Michaud - CHUSJ - Pediatric genomics platform

Jacques Michaud Dr. Michaud is a Fellow of the Royal College of Physicians (Canada) in both Pediatrics and Medical genetics. After completing his medical training at Université de Montréal and University of Toronto, he pursued research training in developmental genetics at the Institut d'Embryologie Cellulaire et Moléculaire du Collège de France et du CNRS in Paris and at the Carnegie Institution of Washington/Johns Hopkins University in Baltimore. He is currently Chief of the Division of Medical Genetics at Hôpital Sainte-Justine, Professor of Pediatrics at Université de Montréal, holder of the Jeanne et Jean-Louis Lévesque Chair and a National Scientist of the Fonds de la Recherche en Santé du Québec (FRSQ). His research interests are centered on the genetic basis of neuro-developmental disorders. In particular, his laboratory has been using large-scale genetic approaches to identify novel genes involved in intellectual disability, epilepsy and autism. His group also found that spontaneous mutations ¿mutations not inherited from the parents ¿ represent a major cause of intellectual disability. Finally, Dr. Michaud is using mouse models to gain insight into the function of these genes and to develop pharmacological treatments of developmental disorders. His research program is funded by the Canadian Institutes of Health Research, Genome Canada, Genome Quebec, FRSQ and the March of Dimes (USA).

+
A16
Nicole Beaudry - Commission de l'éthique en science et en technologie - Commission recommandations

Nicole Beaudry

Nicole Beaudry - Commission de l'éthique en science et en technologie - Commission recommandations

The Commission identified five ethical issues impacting personalized health care: quality of data and security of patients, clinical relationship and medical practice, social implications, ethical data management and ethical management of the limited financial resources of the Québec healthcare system.

Nicole BeaudryMe Nicole Beaudry est Secrétaire générale à la Commission de l'éthique en science et en technologie du Québec. En cette qualité, elle participe à tous les travaux de la Commission et représente cette dernière à plusieurs instances nationales et internationales.
Elle a exercé la profession de notaire en pratique privée durant plus de vingt ans.
Elle détient une maîtrise en éthique de l'Université du Québec à Rimouski et une scolarité de doctorat en droit à l'Université Laval à Québec.
Elle est membre du Comité de discipline de la Chambre des Notaires du Québec dont elle a été boursière pour ses études doctorales. Elle est également membre du Comité d'éthique du Centre Jeunesse de Québec.
Elle a présidé plusieurs conseils d'administration, dont celui du CSSS Vieille Capitale de Québec et a été membre de plusieurs autres, dont l'Association des hôpitaux du Québec et la Caisse centrale Desjardins.

+
A17
Manon Lambert - CRDI Chaudière-Appalaches - The Ipad to serve people with intellectual disability

Manon Lambert

Manon Lambert - CRDI Chaudière-Appalaches - The Ipad to serve people with intellectual disability

Technologies have become an integral part of our lives as well as a complement to our actions or requirements. Digital tablets, along with their various applications, are also of interest to our clientele. It allows for the development of fine motor skills, cognitive functions, communication, autonomy, etc. This is a standardized tool with a simple, instinctive interface that motivates clients. Since the beginning of the project, several clients and their families have stressed the significant contribution of this technology in the achievement of objectives. Technologies at CRDITED de Chaudière-Appalaches are essential to the achievement of its mission notably with respect to the specialization of services.

Manon Lambert Manon Lambert est conseillère-cadre par intérim au CRDITED de Chaudière-Appalaches. Elle détient un baccalauréat en ergothérapie. Comme clinicienne, elle démontre de l'intérêt pour les technologies qui facilitent l'accès à l'ordinateur et pour les contrôles d'environnement. En tant que gestionnaire à l'enfance, elle assure le mandat de chargée de projet pour l'implantation de la tablette numérique en 2012. Aujourd'hui, elle collabore activement avec le comité technoclinique afin de maximiser l'utilisation de ces technologies à des fins d'apprentissage et de soutien à l'autonomie, tant au profit de la clientèle ayant une déficience intellectuelle ou un trouble envahissant du développement que des intervenants.

+
B1
Denis Remon - PRO-innovation - Open innovation as accelerator for patients' results

Denis Remon

Denis Remon - PRO-innovation - Open innovation as accelerator for patients' results

More and more, benefits for the healthcare system include open innovation. It is a genuine technological and healthcare practice accelerator all for the benefit of patients. It proposes new and original solutions to economic, organizational and clinical, and medical issues and it leads to new business models.

Denis Remon Denis Remon a connu une carrière riche en formation et en expérience de travail de tout genre. Ayant cumulé des diplômes dans plusieurs universités (Bible et théologie, éducation, administration des affaires) et écoles de métier (mécanique automobile, boulangerie artisanale, enseignement), où il a obtenu le grade de docteur tant en pédagogie qu'en innovation, il a exercé les rôles d'employé, de gestionnaire, de professeur, de chercheur, de consultant et d'entrepreneur.
Curieux de nature, il s'intéresse à tout, mais surtout aux gens. Il pratique la règle d'or : faire à autrui ce qu'il voudrait qu'on lui fasse. Être premier à vouloir passer en second, relève d'un défi titanesque, aux allures quasi chevaleresques, dans une société de droit, marqué d'un individualisme où noblesse et poésie ont depuis longtemps perdu leur nature.
Denis pense que s'intéresser à l'innovation est la manifestation d'un retard sur ses contemporains. Bien que certains soutiennent que l'innovation est un processus, il soutient, lui, qu'elle est surtout un résultat. Pourquoi? Parce que l'innovation est le résultat-tablette d'une invention ou d'une résolution de problème. En terme technologique, une innovation, c'est l'objet qu'on a entre les mains.
En milieu hospitalier, Denis pense que la fonction du partenariat économique est une des plus stratégiques. Pourquoi? Parce qu'il est accélérateur d'innovations technologiques, organisationnelles et clinico-médicales, selon le cas. L'innovation ouverte est celle qui peut le mieux construire ces relations partenariales. Elle intègre les forces vives du milieu et transforme les relations de collaboration. Il en est passionné.

+
B2
Patrick Dubé - Société des arts technologiques - Emergence of the health living labs

Patrick Dubé

Patrick Dubé - Société des arts technologiques - Emergence of the health living labs

Over the last few years co-creative processes have been brought to international attention because of their technological innovative potential in both the field of technological innovation and social innovation. The healthcare sector is currently one of the most active fields of application for this type of approach.
Despite its vast potential, this type of approach often translates into one-off two-hour workshops, even a whole day, thereby limiting the significance and impacts of these procedures to a mere "work together" effort. Of course, the post-it-type message provides for collective reflection and allows for the expression of different points of views and ideas. However, to fully foster the uptake and establishment of innovation within the healthcare system, it must be concluded that these approaches should be implemented methodically and based on a long-term, broader framework that would include exploration, experimentation and assessment activities making it possible to diversify the mobilization of knowledge and know-how that would foster the generation of new field knowledge.
By means of various international and Québec examples, we will demonstrate how the living lab concept can provide a solid foundation for co-creative approaches within the reality of field work through an open innovation process that is no longer centered on the user but rather promoted by the user for the implementation of testing and implementing this approach in realistic conditions early in the innovation procedure.

Patrick Dubé - Co-founder at Umvelt Service Design Co-director of research & open innovation, Society for Arts and TechnologyAprès une maîtrise en anthropologie des usages et des études doctorales en modélisation des systèmes complexes, Patrick Dubé débute une carrière de chercheur et d'entrepreneur dans le secteur des applications médicales numériques. Depuis 2006, il accompagne les organisations dans le développement de leurs pratiques innovantes et supporte le développement de pratiques d'innovation ouverte auprès de PME, d'OBNL et de municipalités. En 2013 il fonde Umvelt, une firme conseil spécialisée en design de services à l'origine de plusieurs initiatives de living labs dans le secteur de la santé et de projets liés aux villes intelligentes. Il agit également à titre de codirecteur de la recherche et de l'innovation ouverte à la Société des Arts Technologiques et préside aujourd'hui la table montréalaise de concertation des living labs.

+
B3
Luigi Lepanto - Montréal UHC (CHUM) - Intervention ETMIS-Industry to spread innovation: case studies

Luigi Lepanto

Luigi Lepanto - Montréal UHC (CHUM) - Intervention ETMIS-Industry to spread innovation: case studies

The introduction of 3 practical examples that delve into the challenges and opportunities of a collaborative effort between the industry and hospital-based health technology assessment units that is intended to foster innovation and easily and quickly introduce the findings within the healthcare system.

Luigi Lepanto Dr Luigi Lepanto est adjoint au directeur (volet évaluation des technologies, des modes d'intervention en santé et performance) à la Direction de la qualité, de l'évaluation et de la planification stratégique du Centre hospitalier de l'Université de Montréal (CHUM). Dr Lepanto est également radiologue, spécialiste en imagerie abdominale au CHUM. Il est professeur titulaire de clinique au Département de radiologie, radio-oncologie et médecine nucléaire de la Faculté de médecine de l'Université de Montréal. Il a une affiliation secondaire au Département d'administration de la santé de l'École de Santé publique et il est le directeur canadien du programme de maîtrise Ulysse, un programme de maîtrise internationale en gestion et évaluation des technologies de la santé. Dr Lepanto s'intéresse aux technologies diagnostiques et leur impact sur la trajectoire de soins, aux technologies de l'information appliquées à la santé ainsi qu'aux interventions complexes combinant l'implantation de technologies à l'introduction de changements de processus dans la prestation des soins. Il appuie la collaboration soutenue entre l'industrie et les unités d'évaluation des technologies de la santé en milieu hospitalier, afin de favoriser l'innovation et de faciliter leur introduction dans le système de santé.

+
B4
Diane Côté - Medteq - Innovation implementation

Diane Côté

Diane Côté - Medteq - Innovation implementation

Diane Côté
Diane Côté is CEO of the MEDTEQ Industrial Research and Innovation Consortium whose objective it is to accelerate the development of innovative medical technologies. She was previously Vice-President - Quebec of MEDEC, the national association created by and for the Canadian medtech industry.

Formerly Ms. Côté was CEO of a medical technology company specialising in state-of-the-art mathematical modeling and neural networks for risk management purposes. She worked at IBM as a member of the Sales and Communications management team. She also lead numerous mandates in strategic planning, financing and partnerships at Innovitech, a consulting company focusing on new technologies and on the development of innovative economic models.

+
B5
Martin Lamarre - Quebec UHC - Modernization of medical leaders' role in the support for clinical innovation

Martin Lamarre, M.D.

Martin Lamarre - Quebec UHC - Modernization of medical leaders' role in the support for clinical innovation

The role of medical leaders in carrying out the implementation of innovation and clinical governance is evolving. This workshop is intended to share the various approaches that are adopted at CHU de Québec as well as those being developed to address the modernization of the clinical governance model.

Martin Lamarre, M.D.Directeur des services professionnels
CHU de Québec
L'Hôtel-Dieu de Québec

Le titre de ma conférence : Modernisation du rôle des leaders médicaux dans le soutien à l'innovation clinique au CHU de Québec

+
B6
René Déry - Director, Supply Chain Solutions, McKesson Canada

René Déry

René Déry - Pharmacy Supply Chain Solutions

 

René Déry In 2013, McKesson Canada was selected as New Brunsw ick's preferred service provider of a entralized, single-source pharmaceutical supply chain model. Using its understanding of the province's challenges, McKesson Canada's model is specifically designed to meet the needs of hospitals province-wide.
The model ensures the best use of human, financial and technological resources, while establishing a single point of accountability. Operational and cost efficiencies are achieved through a committed private/public sector partnership in which each partner uses their respective areas of expertise to jointly develop and implement best practices, measure performance and make continuous improvements.

+
B7
Annie Rainville - CHUSJ - Users' Committee

Annie Rainville

Annie Rainville - CHUSJ - Users' Committee

 

Annie Rainville travaille comme avocate à l'Aide juridique de Montréal, section civile et est chargée de cours à la Faculté de droit de l'UDM. Elle termine actuellement une maîtrise en droit et politiques de la santé. Elle est également présidente du comité des usagers et siège au sein des comités suivant de l'établissement: CA, comité exécutif du CA (comité administratif), comité de vigilance et de la qualité.

 

+
B8
Jasmine Martineau & Stéphane Tremblay - Quebec UHC - Skills development in an experimental model of interprofessional collaboration

Jasmine Martineau

Stéphane Tremblay

Jasmine Martineau & Stéphane Tremblay - Quebec UHC - Skills development in an experimental model of interprofessional collaboration

In the wake of the creation of CHU du Québec, several challenges and clinical opportunities contributed to the establishment of an inter-professional and cooperative organizational strategy. Direction des services multidisciplinaires along with the assistance of internal and external partners such as Réseau de collaboration sur les pratiques interprofessionnelles en santé et services sociaux of Université Laval connected with RUIS have implemented team training and support programs intended to support the implementation of an interprofessionnal cooperation culture. One of the cornerstones of this strategy is the experiential training and support model that draws on the tacit knowledge of clinical staff.

Jasmine Martineau

Stéphane Tremblay

+
B9
David Chelo - Centre Mère-enfant (Cameroun) - Field Knowledge: a necessity for the under 5 years old mortality reduction in Cameroon

David Chelo

David Chelo - Centre Mère-enfant (Cameroun) - Field Knowledge: a necessity for the under 5 years old mortality reduction in Cameroon

For almost 4 decades, the infant and child mortality rate has been diminishing exceptionally slowly in Cameroon. It remains today at a clearly unacceptable level. More than one-third of children within the community die. Community care and support for children is indeed heavily influenced by taboos, culture and other traditional beliefs. A dramatic reduction in mortality should take into account these local realities, hence the need for individuals that could serve as an interface between the general population and the specialized services.

 

+
B10
Yannick Beaulieu - Sacré-Coeur Hospital- REACTS Platform

Yannick Beaulieu

Yannick Beaulieu - Sacré-Coeur Hospital- REACTS Platform

Reacts (Remote Education, Augmented Communication, Training and Supervision) integrates into one single secured platform tools that enable video conferencing, file sharing and transfer, collaborative work, assessment of skills and know-how, and shared applications and screens, while integrating innovative methods such as augmented reality applications and the superimposition of real-time images. Reacts was designed with the intention of optimizing health care quality, the patient experience and the teaching and transfer of knowledge and know-how. With Reacts, the telepresence application becomes a "hyperpresence" experience.

Yannick Beaulieu Le Dr. Yanick Beaulieu est cardiologue et intensiviste à l'hôpital sacré-Coeur de Montréal et professeur adjoint de clinique à l'université de Montréal. Depuis les dix dernières années, le Dr Beaulieu a conçu divers curriculum d'enseignement utilisant le multimédia et a publié plusieurs articles et chapitres de livres.

Depuis plus de deux ans il travaille à l'élaboration d'une plateforme web novatrice qui a pour but de faciliter les communications et l'interaction audio-vidéo et multimédia entre professionnels ainsi qu'avec les patients. Plusieurs projets pilotes utilisant sa plateforme sont sur le point de commencer dans diverses disciplines médicales telles la neurochirurgie, la dialyse péritonéale, la transplantantion pulmonaire, la réimplantation de la main, et la simulation médicale.

+
B11
Jorge Juan Fernandez - Hospital San Juan de Déu, Spain - The Liquid Hospital

Jorge Juan Fernandez

Jorge Juan Fernandez - Hospital San Juan de Déu, Spain - The Liquid Hospital

What is a Liquid Hospital? This initiative by Hospital Sant Joan de Déu (HSJD) encompasses more than 20 projects seeking to radically transform healthcare through an intensive use of technologies oriented towards the patient. HSJD aims to be a Liquid Hospital, providing services and content for the patients beyond the physical buildings of the hospital. HSJD is the most relevant example in Europe where a hospital is using online care, telemedicine, mobile apps and health 2.0 tools to put the patient in the center of care. The only reason why we are interested in technologies is because they can help us solve the healthcare conundrum. Or can you think of any better ways of providing better care, at a lower cost, and more accessible?

Jorge Juan Fernandez

+
B12
Céline Crowe - Institut Universitaire de Gériatrie de Montréal - Tele-PsychoGeriatrics

Céline Crowe

Céline Crowe - Institut Universitaire de Gériatrie de Montréal - Tele-PsychoGeriatrics

More and more emphasis is placed on the predictive and clinical importance and the prognosis of behavioural and psychological symptoms of dementia (BPSD). In fact, almost all patients (80 to 97%) with dementia will exhibit these types of symptoms at one time or another during their disease. Various organizations have emphasized the difficulty in receiving expert support for the management of BPSD. The Alzheimer's report published in Québec emphasizes the lack or inadequacy of training in the behavioural and psychological symptoms of dementia which results in suboptimal management of this problem and overuse of antipsychotic drugs. Studies have shown the feasibility of assessing the cognition of seniors using videoconferencing while others support the relevance of telepsychiatry for following up on dementia patients displaying BPSD symptoms. Hence, the BPSD team at Montreal Geriatric University Institute has introduced a project intended to offer health care stakeholders remote access to specialized psychogeriatric resources in order to support them with the assessment, medical treatment and follow-up of their senior clientele suffering from severe behavioural and psychological problems associated with dementia. The service is offered to those institutions wishing to set up a second-line BPSD care team. While using telehealth, we offer this interdisciplinary team's consultation, training and mentoring services. After approximately ten tele-expertises, the second-line team becomes autonomous with respect to the assessment and management of BPSD and our expert team remains on board as the third-line support team. These efforts contribute to the development of a graded service organization that fosters the empowerment of regions and a high-quality neighbourhood service for clients.

Céline CroweDiplômée de l'Université de Montréal, puis du Collège des médecins de famille du Canada, Dre Crowe a travaillé 3 ans en bureau privé pour ensuite axer sa pratique en gériatrie. Elle a exercé la médecine de 1982 à 1988 à l'Institut universitaire de gériatrie de Montréal et occupe, depuis 1988, le poste de directrice du développement et des affaires médicales dans cet établissement.

Elle participe à l'enseignement de l'éthique à l'Université de Montréal où elle détient un poste de chargé d'enseignement clinique et a mis sur pied tant le comité d'éthique de la recherche que le comité d'éthique clinique de l'IUGM. Elle participe à plusieurs comités touchant la gériatrie et l'organisation des services au sein d'associations, d'organismes, du Réseau universitaire intégré en santé (RUIS) de l'Université de Montréal, de l'Agence de la santé et des services sociaux de Montréal et du ministère de la Santé et des Services sociaux. Elle accompagne des établissements en santé dans la révision de leur organisation de services aux personnes âgées et préside le comité directeur du Centre d'expertise en douleur chronique du RUIS de l'Université de Montréal. Elle a été chargée de projet pour l'Approche adaptée à la personne âgée en milieu hospitalier, en implantation dans tous les centres hospitaliers du Québec.

Docteure Crowe a participé à l'organisation de nombreux colloques, dont deux internationaux, et elle est sollicitée à titre de conférencière à plusieurs congrès et colloques.

+
B13
Antonio D'Angelo -CHUSJ - Teletrauma in CHU Sainte-Justine Emergency

Antonio D'Angelo

Antonio D'Angelo -CHUSJ - Teletrauma in CHU Sainte-Justine Emergency

The presentation will answer the following questions:
¿ What is teletrauma?
¿ In what purpose is it useful?
¿ How to measure the impact?

The objectives of the presentation are:
1. After the presentation, the participant should know the importance and role of the general telemedicine and the teletrauma specifically in the initial care and the assistance of a secure transfer of a seriously sick patient.
2. The experience of teletrauma in Sainte-Justine UHC.

 

+
B14
François Reeves - Université de Montréal - Heart, Gene and Milieu

Dr François Reeves MD LMSQ FRCPC

François Reeves - Université de Montréal - Heart, Gene and Milieu

Aujourd'hui, le milieu, autrefois sous-estimé en maladie cardiovasculaire, appert pour être un facteur de risque non seulement puissant mais aussi hautement modulable. Nous réalisons que la révolution industrielle a introduit des nano-agresseurs alimentaires et aériens auxquels nos ancêtres pré-anthropocène n'étaient pas exposés.
Non seulement ces nano-agresseurs ont-ils une toxicité directe sur nos vaisseaux, provoquant athérosclérose, thrombose et dysfonctionnement du système nerveux autonome, mais ils induisent également les facteurs dits classiques soient hypertension, diabète, dyslipidémie et même obésité. La conjonction de ces nano-agresseurs aériens et alimentaires se potentialisent mutuellement et entrainent une « tempête cardiovasculaire parfaite », laquelle s'observe dans les sociétés émergentes reproduisant la révolution industrielle nord-américaine des années 50. On estime qu'au Canada (2008), les maladies attribuables aux causes environnementales ont couté plus de 9 milliards de dollars et ont causés plus de 20 000 décès excédentaires, dont les deux-tiers sont cardiovasculaires.

Dr François Reeves MD LMSQ FRCPCInterventional Cardiologist; Associate Professor of Medicine, Faculty of Medicine;
affiliated with the Environmental Health Department, Public Health School;
University of Montreal
Author, Prévenir l'infarctus ou y survivre (2007), Planète Coeur (2011), Planet Heart (2014)

 

 

+
B15
Catherine Litalien -CHUSJ - Optime

Catherine Litalien

Catherine Litalien -CHUSJ - Optime

Download the presentation

 

+
B16
Patrick Tremblay - Caprion - Personalized health and cancer

Patrick Tremblay

Patrick Tremblay - Caprion - Personalized health and cancer

 

 

+
B17
Julie Duguay - Centre de réadaptation Estrie - Personalized health project for rehabilitation

Julie Duguay

Julie Duguay - Centre de réadaptation Estrie - Personalized health project for rehabilitation

Plusieurs clientèles requérant des interventions en neuropsychologie au Centre de réadaptation Estrie présentent des enjeux de mémoire de travail. Au programme Adultes, nous utilisons un programme de remédiation de la mémoire de travail sur informatique qui, non seulement donne des résultats significatifs sur les habitudes de vie des usagers mais réduit également le temps direct d'intervention requis par les intervenants. L'usager devant effectuer ses exercices du domicile, cette nouvelle avenue dans l'offre de service favorise l'autodétermination et l'autonomie des usagers. Cette forme personnalisée d'intervention prend donc tout son sens tant du point de vue de l'usager, de l'intervenant que du gestionnaire.

Julie Duguay Chef de programme-Adultes, Centre de Réadaptation Estrie

P1 How to set up a Quebec network of innovation implementation?

MODERATORS:

  • Jacques Turgeon, B.Pharm., Ph.D., FCAHS CEO CHUM
  • Fabrice Brunet Chairman of Conférence des CHU du Québec & CEO CHU Sainte-Justine

PANELISTS:

  • Jacques Turgeon, B.Pharm., Ph.D., FCAHS Directeur général, CHUM
  • Heather Chalmers Eng, MBAGE HealthCare Canada
  • Véronique Déry INESSS
  • Stephen Saunders CGI

P2 How to institutionalize the innovations from the field within a formal structures?

MODERATORS:

  • Ahmed Maherzi Dean and Pediatric Professor of the Faculty of Medicine of Tunis & Head of Department of Pediatrics and Neonatalogy at the University Hospital La Marsa Mongi Slim
  • Liza Frulla

PANELISTS:

  • Lucie Dumas CEO, Réseau Planetree Québec
  • David CheloCentre Mère-Enfants, Cameroun
  • Louis ThériaultExecutive Director, Economic Initiatives

P3 How to set up a telehealth project using a multidimensionnal approach?

MODERATORS:

  • Johanne Castonguay Associate VP Cirano
  • Gertrude BourdonCEO CHUQ

PANELISTS:

  • Narendra Kini
  • Ms. Edith Deleury
  • Marie-Josée Paquet CHUM
  • Jorge Juan Fernandez Hospital San Juan de Déu, Espagne

P4 How will personalized health transform the healthcare system?

MODERATORS:

  • Howard Bergman MD, FCFP, FRCPC Chair, Department of Family Medicine | Professor of Family Medicine, Medicine and Oncology |The Dr. Joseph Kaufmann Professor of Geriatric Medicine | McGill University

PANELISTS:

  • Guy Rouleau (UdM) - MD, PhD, FRCP(C), OQChairholder of the Wilder Penfield Chair in Neuroscience Director of the Montreal Neurological Institute and Hospital Chair of the Department of Neurology and Neurosurgery at McGill University Director of the Réseau de Médecine Génétique Appliquée - FRSQ
  • Jean-Claude Forest MD, PhD, FRCPC, FCAHS
  • Joanne Castonguay Vice-présidente adjointe, Cirano
  • Dr. Anjali Agrawal Senior Managing Consultant, Healthcare Transformation IBM Watson Group
  • Normand Rinfret

Sponsored Lunch Session

+
LUNCH
07-OCTOBRE
L'innovation-au bout des doigts! : Dans le contexte difficile du réseau, l'innovation ne peut pas rester un concept de haut niveau, associé à une structure, à une division ou simplement aux technologies. L'innovation devra prendre tout son sens directement sur le terrain, dans le quotidien des intervenants et des usagers, et dans le modèle de prestation de soins et services.

Jonathan Perrier

Maria Fontino

L'innovation... au bout des doigts!

Dans le contexte difficile du réseau, l'innovation ne peut pas rester un concept de haut niveau, associé à une structure, à une division ou simplement aux technologies. L'innovation devra prendre tout son sens directement sur le terrain, dans le quotidien des intervenants et des usagers, et dans le modèle de prestation de soins et services. Cette innovation de « proximité » devra être reconnue comme de l'innovation de première importance, essentielle, voire vitale à la survie du réseau de la santé.
La conférence abordera donc le thème de l'innovation sous l'angle de l'importance d'innover dans le modèle de prestation de soins et services, de miser sur la collaboration pour le faire (intra et intersectoriel) et sur le rôle clé des gestionnaires de premier niveau.

Jonathan Perrier. M. Jonathan Perrier est conseiller principal au sein du Groupe-conseil stratégie et performance chez Raymond Chabot Grant Thornton. Il compte 13 ans d'expérience dans le secteur des soins de santé, dont cinq en services-conseils. Il est titulaire d'un baccalauréat en sciences infirmières et d'une maîtrise en administration de la santé. Il est également certifié Ceinture noire Lean Six Sigma.
M. Perrier a contribué à plusieurs dossiers de programmation clinique et de planification stratégique au cours des cinq dernières années. Il s'est également spécialisé en optimisation des processus et en analyse de la performance opérationnelle et financière. Ainsi, il a participé à plus d'une trentaine de projets dans des secteurs cliniques du réseau de la santé, et des secteurs administratifs au sein de ministères et organismes provinciaux. Dans l'ensemble de ses projets, il a travaillé de près avec les équipes terrain et a pu constater leur grande capacité d'innovation. Finalement, M. Perrier est également chargé de cours au programme de maîtrise en administration de la santé à l'Université de Montréal, où il enseigne la gestion des processus de santé et de services sociaux.

Maria Fortino Mme Maria Fortino est directrice principale au sein du Groupe-conseil stratégie et performance chez Raymond Chabot Grant Thornton. Elle compte 15 années d'expérience dans le secteur des soins de santé, dont sept en services-conseils. Elle détient une maîtrise en administration des affaires ainsi qu'un baccalauréat en Sciences de la nutrition. Elle est également certifiée Ceinture noire Lean Six Sigma. Professionnelle dynamique, elle a accompagné près de 35 établissements du réseau dans divers mandats portant, entre autres, sur l'amélioration de la performance globale, l'optimisation des processus et la réorganisation du travail. Mme Fortino a également accompagné des équipes de direction dans la réalisation de planifications stratégiques, d'études d'opportunités et de restructurations organisationnelles visant à soutenir la réalisation de la mission et l'atteinte des objectifs des établissements. Mme Fortino compte aussi à son actif plusieurs projets d'amélioration des processus d'assurance-qualité et de contrôle de la qualité, ayant pour but de réduire les risques liés à la production et à la distribution d'aliments de consommation. Ces projets lui ont permis de confirmer sa capacité d'analyse, de développer une compréhension fine des défis liés à la transformation des organisations et de maîtriser les éléments de conduite du changement essentiels à l'amélioration et à l'innovation.

+
LUNCH
8-OCTOBER
Roche Canada - Lunch Sponsorship

François Drolet

Ian Kallmayer

Ian Parfrement

Precision Medicine / Personalized Healthcare

The aim of personalized healthcare is to make modern medical care more systematic and more effective. It enables identification of differences between groups of patients and improves the understanding of disease sub-categories. This information can be used to (a) find the best targets for new medicines and (b) to come up with new biomarkers and diagnostic tests.

Patients have benefitted from advances in both biological and medical insights, including the development of more than 100 drugs whose labels now include pharmacogeneomic information. Patients with melanoma, leukemia or metastatic lung, breast or brain cancers may now routinely be offered a molecular diagnosis in to allow their doctors to select a precision medicine that target the underlying driver of their disease process. Treatments targeting these particular gene mutations represent a remarkable improvement over trial and error medicine, where physicians do their best to try and provide the best treatment, but without having the specific information about the underlying disease process for that patient.

Patients, doctors and payers expect the pharmaceutical industry to deliver new, innovative, safe and cost effective therapies, with the overall goal to a) optimize the riskbenefit ratio and b) improve the cost-benefit ratio of medicines. In many cases, precision medicines have already achieved this and the work continues.

The Value of Diagnostics

Building on the previous presentation highlighting the accelerated development of personalized healthcare / precision medicine and their associated benefits for all stakeholders across the patient care continuum, we will touch on the imbalance between the vital contribution laboratory medicine brings to the delivery of patient care and how it has been traditionally funded.

Indeed, while laboratory information makes up over 80% of a patient health record with up to 70% of all medical decisions being based on that information, only approximately 2% of healthcare funding is allocated to the laboratory.

With more and more drugs having a companion diagnostics and the concept of companion diagnostics quickly evolving from the current single biomarker model to eventually multiplex/panel genetic testing, there is a tidal wave of precision medicines just around the corner that necessitates a shift in how labs are valued within the healthcare ecosystem.

We will also highlight the importance to review the existing reimbursement mechanisms that are not conducive of a synchronized approval and adoption of the new reality of a drug/biomarker combination.

François Drolet. François Drolet joined Roche Diagnostics Canada in 2010. After spending the last 4 years as the Canadian head of sales for Professional Diagnostics, François is now Director of Business Development, a function just recently created within the Canadian organization. In this new role, François is responsible for all business development initiatives, market access and reimbursement and government relations. He also oversees a team of Strategic Account Managers a unique model around the world with these individuals representing both the Pharmaceutical and Diagnostics divisions. Their roles are to develop and maintain partnerships with hospital senior leaders. Prior to joining Roche Diagnostics Canada, François spent over 20 years with Covidien in various Sales and Marketing positions and serving his last 8 years with the company as the Canadian Vice-President of Sales & Marketing. Always in keeping with a patient centric approach, his 25 years spent within the healthcare industry and more specifically in the Operating Room, ICU, Medical Imaging, Nuclear Medicine, Anesthesiology, Nursing in general and now Laboratory Medicine have provided him with great insight into our healthcare ecosystem. François earned a bachelor's degree in Commerce and Administration from Laval University in Quebec City and he is a member of the Canadian College of Health Leaders while acting as a Roche representative in many industry forums.

Ian Kallmayer. Ian began his career in the pharmaceutical industry with Astra Pharma as Supervisor of the Microbiology Laboratory. Ian then moved to Roche to take a position in regulatory affairs. He then took on a primary care sales role and further rounded out his experience through progressive positions in medical marketing and product management. In 2005, Ian joined the newly formed rheumatology business unit as Director of Medical Marketing and launched two new innovative biologics for the treatment of rheumatoid arthritis. He was then appointed the Business Unit Director for Rituxan RA. Ian is currently Director, New Product and Portfolio Planning where his focus is on early commercialization strategy for Roche's pipeline. Ian has an Honours Bachelor of Science degree in microbiology and biotechnology from the University of Guelph.




Ian Parfrement. Ian Parfrement joined Roche Diagnostics Canada in June 2012 as President and General Manager and is a member of the North American Diagnostics Executive Committee. He is an active member of the Board of Directors of Montreal InVivo and Quebec Network for Personalized Healthcare. Ian's career started with Boehringer Mannheim, United Kingdom, in 1991 as a Sales Representative and steadily took on increasing responsibilities across each business area within Roche UK and Ireland. In 2004, Ian was appointed Director Hospital IVD responsible for UK and Ireland Sales and Marketing activities across Molecular Diagnostics, Centralized Diagnostics and Hospital Point of Care portfolio. For five years, Ian was a member of the European wide Regional Working Group focused on Roche Centralized Diagnostics, led the Regional Subteam for Centralized Diagnostics Analytical Systems, and for two years was the European Regional Representative for high volume systems. .

SCIENTIFIC COMMITTEE

The Scientific Committee of FSI 2014 gathers scientists and professionals from diverse backgrounds who have recognized expertise in science, technology and innovation, Its role is to support the President of FSI in the reviewing the submitted Paper proposals.

FABRICE BRUNET

CEO, Sainte-Justine UHC; President FSI

MARIE RENAUD

Acting Coordinator for International Relations, CHU Sainte- Justine
 

MARIE-HÉLÈNE JOBIN

Director of Health Division HEC Montreal ; Professor, Operations Management and Logistics, HEC Montréal

RÉAL JACOB

Professor of Management and Director, Development of knowledge and Training of Managers, HEC Montreal

LUC SIROIS

Co- Founder and Leader, Hacking Health

JOANNE CASTONGUAY

Assistant Vice-President, CIRANO

GILLES SAVARD

Director of Research and Innovation, École Polytechnique

RENÉE DESCOTEAUX

Director of Nursing, CHU Sainte-Justine

JASMINE MARTINEAU

Director of Multidisciplinary Services, CHU de Québec

DANIEL LA ROCHE

Director, Assessment , Quality and Strategic planning, CHU de Québec

DAVID LEVINE

President, DL Strategic Consulting

ANNIE RAINVILLE

President of the Users' Committee, CHU Sainte-Justine

BRUNO BISSONNETTE, MD

Professor of Anesthesiology, Pain Medicine and Critical Care Medicine, Founder and President of the Board of Trustees Children of the World Anesthesia Foundation, International Medical Adviser

MARK WIETECHA

President of the Users' Committee, CHU Sainte-Justine

JEANNE-ÉVELYNE TURGEON

Directrice, Direction de la qualité, de l'évaluation et de la planification stratégique, CHUM

NICOLE ROSSET

Secrétaire générale adjointe, Hôpitaux universitaires de Genève, Deputy Secretary General of Geneva University Hospitals

JEAN-FRANCOIS DHAINAUT

Professeur de l'Université Paris Descartes et Consultant à l'Assistance Publique - Hôpitaux de Paris (AP-HP), Président du Groupement interrégional de la recherche clinique et de l'innovation (GIRCI) en Île-de-France et Président du Haut Conseil des Biotechnologies

ORGANIZERS

Eventium is a leading company specialized in developping international trade shows and congresses in Montreal.

Les CHU du Québec is defined as an environment dedicated to the academic University hospitals, it is a place that fosters the development of ideas, proposals, and promotes joint policy.

   

El contenido web seleccionado ya no existe.